![](/img/cover-not-exists.png)
O-086a Randomized phase II/III trial of paclitaxel (P) plus carboplatin (C)with or without bevacizumab (NSC #704865) in patients with advanced non-squamous non-small cell lung cancer (NSCLC): An Eastern Cooperative Oncology Group (ECOG) Trial — E4599
Sandler, A.B., Gray, R., Brahmer, J., Dowlati, A., Schiller, J.H., Perry, M.C., Johnson, D.H.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80220-x
Date:
July, 2005
File:
PDF, 151 KB
english, 2005